title: Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
authors.affiliation: Department of Medicine, University of Münster, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Büchner
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: G
authors.initials: G
authors.lastname: Löffler
authors.forename: W
authors.initials: W
authors.lastname: Gassmann
authors.forename: G
authors.initials: G
authors.lastname: Maschmeyer
authors.forename: W
authors.initials: W
authors.lastname: Heit
authors.forename: D
authors.initials: D
authors.lastname: Hossfeld
authors.forename: H
authors.initials: H
authors.lastname: Weh
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: E
authors.initials: E
authors.lastname: Thiel
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin